Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Zovaglutide (ZT002 Injection) in overweight and obese adults, including participants with impaired kidney function and healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zovaglutide (ZT002 Injection) (Zovaglutide)

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight , Obesity | Phase 1 | Status: RECRUITING